Craig Hendrix

Professor

1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Craig Hendrix is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Tenofovir Medicine & Life Sciences
HIV Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Gels Medicine & Life Sciences
Anti-Infective Agents Medicine & Life Sciences
Safety Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study

Ojeda, V. D., Amico, K. R., Hughes, J. P., Wilson, E., Li, M., Holtz, T. H., Chitwarakorn, A., Grant, R. M., Dye, B. J., Bekker, L. G., Mannheimer, S., Marzinke, M. A. & Hendrix, C., Sep 1 2019, In : Journal of acquired immune deficiency syndromes (1999). 82, 1, p. 34-40 7 p.

Research output: Contribution to journalArticle

Disclosure
Risk-Taking
HIV
Tenofovir
Condoms

Pharmacokinetics of dapivirine transfer into blood plasma, breast milk, and cervicovaginal fluid of lactating women using the dapivirine vaginal ring

Noguchi, L. M., Hoesley, C., Kelly, C., Scheckter, R., Bunge, K., Nel, A., Marzinke, M. A., Hendrix, C., Dezzutti, C. S., Hillier, S. L., Bogen, D. L., Piper, J. M. & Beigi, R. H., Mar 1 2019, In : Antimicrobial agents and chemotherapy. e01930-18.

Research output: Contribution to journalArticle

Female Contraceptive Devices
Human Milk
Pharmacokinetics
Milk
Sexually Transmitted Diseases

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

Chen, B. A., Zhang, J., Gundacker, H. M., Hendrix, C., Hoesley, C. J., Salata, R. A., Dezzutti, C. S., Van Der Straten, A., Hall, W. B., Jacobson, C. E., Johnson, S., Mcgowan, I., Nel, A. M., Soto-Torres, L. & Marzinke, M. A., Mar 19 2019, In : Clinical Infectious Diseases. 68, 7, p. 1144-1151 8 p.

Research output: Contribution to journalArticle

Female Contraceptive Devices
Pharmacokinetics
Safety
Placebos
TMC120-R147681

Pre-exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study

Wheeler, D. P., Fields, S. D., Beauchamp, G., Chen, Y. Q., Emel, L. M., Hightow-Weidman, L., Hucks-Ortiz, C., Kuo, I., Lucas, J., Magnus, M., Mayer, K. H., Nelson, L. R. E., Hendrix, C., Piwowar-Manning, E., Shoptaw, S., Watkins, P., Watson, C. C. & Wilton, L., Feb 1 2019, In : Journal of the International AIDS Society. 22, 2, e25223.

Research output: Contribution to journalArticle

Open Access
HIV
Confidence Intervals
Odds Ratio
Tenofovir
Pre-Exposure Prophylaxis

Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa

Matthews, L. T., Jaggernath, M., Kriel, Y., Smith, P. M., O'Neil, K., Haberer, J. E., Hendrix, C., Baeten, J. M., Ware, N. C., Wirth, K., Psaros, C., Bangsberg, D. R. & Smit, J. A., Jul 26 2019, In : BMJ open. 9, 7, p. e027227

Research output: Contribution to journalArticle

Open Access
Tenofovir
South Africa
Longitudinal Studies
HIV
Pregnancy